Long-term health risks linger for severe COVID-19 patients three years after hospitalization

FHS
June 3, 2024
2:23 am

Three years after severe COVID-19 hospitalization, significant risks of mortality and long-term symptoms persist, impacting overall health and quality of life.

Mapping tiny corneal nerves to untangle ocular mysteries

Consider the cornea if you will – and most people won’t unless they’re having a problem. It is the transparent front surface of the eye

January 3, 2024

New study reveals how genes can alter the cancer-fighting power of fruits and fiber

A study in eBioMedicine uncovers two genetic loci that modify the impact of fiber and fruit intake on colorectal cancer risk, highlighting gene-diet interactions.

May 22, 2024

Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 09.11.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.